Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial Envelope
Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial Envelope
复制标题
DOI:
10.1111/j.1540-8159.2010.02931.x
复制
发表时间:
2011-02-01
影响因子:
1.8
通讯作者:
Sohail, Muhammad R.
中科院分区:
文献类型:
--
作者:
Bloom, Heather L.;Constantin, Luis;Sohail, Muhammad R.
Methods: This study enrolled consecutive CIED procedures utilizing the antibacterial envelope at 10 US academic, community, and Veterans Affairs medical centers. Procedures following an explantation for a prior CIED infection or off-label use of the antibacterial envelope were excluded.Results: The 624 eligible procedures (age 70 +/- 13 years, 68.1% men, 27.2% renal insufficiency, 35.4% oral anticoagulant use, 67.8% replacement/revision procedures) utilized pacemakers (35%), implantable cardioverter-defibrillators (ICD)(29%), and cardiac resynchronization therapy with defibrillator devices (CRT-D)(36%). Nearly half of the patients (49%) had at least three predefined risk factors for CIED infection. CIED implantation was successful in 621 procedures (99.5% [95% confidence interval (CI) 98.8-99.9]). There were three major infections (0.48% [95%CI 0.17-1.40]) after 1.9 +/- 2.4 months follow-up. The infections followed one ICD revision and two CRT-D replacements. There were seven deaths; none was a result of the antibacterial envelope or the CIED procedure.Conclusions: CIED procedures that utilized an antibacterial envelope had a high rate of CIED implantation success (> 99%). Although the follow-up to date is short, there was also a low rate of infection (< 0.50%) in this population at high risk for CIED infection. (PACE 2011; 34:133-142).